Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few What Science ACTUALLY Says About BPC 157 Benefits Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed Gray Market Peptides: So Much Hype, So Little Data